# Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)

> **NCT01609348** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 5 (actual)

## Conditions studied

- Alzheimer's Disease
- Depression

## Interventions

- **DRUG:** Placebo
- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT01609348
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609348, "Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01609348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*